Form 8-K - Current report:
SEC Accession No. 0001193125-21-277718
Filing Date
2021-09-21
Accepted
2021-09-21 06:05:02
Documents
14
Period of Report
2021-09-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d164672d8k.htm   iXBRL 8-K 34697
2 EX-3.1 d164672dex31.htm EX-3.1 151299
3 EX-3.2 d164672dex32.htm EX-3.2 8116
  Complete submission text file 0001193125-21-277718.txt   357314

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20210915.xsd EX-101.SCH 2915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20210915_lab.xml EX-101.LAB 18889
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20210915_pre.xml EX-101.PRE 11875
7 EXTRACTED XBRL INSTANCE DOCUMENT d164672d8k_htm.xml XML 3602
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 211264777
SIC: 3841 Surgical & Medical Instruments & Apparatus